MAGNEGITA

This brand name is authorized in Estonia, Lithuania, South Africa

Active ingredients

The drug MAGNEGITA contains one active pharmaceutical ingredient (API):

1 Gadopentetate dimeglumine
UNII RH248G8V27 - GADOPENTETATE DIMEGLUMINE

Gadopentetic acid is a paramagnetic contrast agent for magnetic resonance imaging.

Read about Gadopentetate dimeglumine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V08CA01 Gadopentetic acid V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1240883, 1240894, 1240906, 1240917, 1240928, 1240939, 1240940, 1240962, 1240973, 1240984, 1240995
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1022790, 1033914, 1033915, 1033916, 1033917, 1033918, 1033919, 1033920, 1033921, 1033922, 1033923, 1033924
Country: ZA Health Products Regulatory Authority Identifier(s): 44/28/0236, 44/28/0237, 44/28/0238, 44/28/0239, 44/28/0240, 44/28/0241

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈